Chapter 20. Treatment of Chronic Hepatitis B

  1. Howard Thomas BSc PhD FRCP FRCpath FMedSci Professor1,
  2. Stanley Lemon Professor2 and
  3. Arie Zuckerman MD, DSc, FRCP, FRCPath, FMedSci, Dip. Bact Professor3
  1. Patrick Marcellin,
  2. Tarik Asselah and
  3. Nathalie Boyer

Published Online: 26 OCT 2007

DOI: 10.1002/9780470987131.ch20

Viral Hepatitis, Third Edition

Viral Hepatitis, Third Edition

How to Cite

Marcellin, P., Asselah, T. and Boyer, N. (2005) Treatment of Chronic Hepatitis B, in Viral Hepatitis, Third Edition (eds H. Thomas, S. Lemon and A. Zuckerman), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470987131.ch20

Editor Information

  1. 1

    Dean (Clinical) Faculty of Medicine, Imperial College, Department of Medicine, Queen Elizabeth Queen Mother Wing, St Mary's Hospital Medical School, London UK

  2. 2

    Dean of Medicine, Department of Microbiology & Immunology & Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA

  3. 3

    The Royal Free Hospital of Medicine, Rowland Hill Street, London, UK

Publication History

  1. Published Online: 26 OCT 2007
  2. Published Print: 12 JUL 2005

ISBN Information

Print ISBN: 9781405130059

Online ISBN: 9780470987131



  • chronic hepatitis B;
  • lamivudine therapy;
  • adefovir dipivoxil;
  • pegylated IFN;
  • entecavir


This chapter contains sections titled:

  • Introduction

  • Natural history of chronic hepatitis B

  • Objectives of treatment

  • Current treatments

  • New treatments

  • New antivirals

  • Summary